Genetics
  • Videos
  • December 2019
  • 17:29 minutes

Liquid Biopsies

Fact, Fiction, or Both?

By
  • Dr. Daniel D. Zimmerman

Is science fiction becoming science fact? Liquid biopsies are a new class of blood- (or other bodily fluid-based) tests that can reveal direct evidence of cancer and are far less invasive than traditional biopsies. RGA's Dr. Daniel Zimmerman explores linkages between advances in genetics and this new technology. He also investigates limitations, potential mortality and morbidity impacts, and insurance implications. 

If you would like to discuss this webcast further please e-mail us at: [email protected]

 

More Like This...

  • Articles
    July 2018
    How Liquid Biopsies Could Transform Insurance Medicine
    Read More
  • Research and White Papers
    July 2018
    Liquid Biopsy: The RGA Perspective
    Read More
  • Publications
    February 2018
    Global Health Brief – Liquid Biopsy
    Read More
  • Articles
    March 2017
    Precision Medicine
    Read More
  • Articles
    March 2019
    Precision Medicine and Targeted Cancer Therapy
    Read More
  • Publications
    September 2018
    Global Health Brief: Stem Cell Therapy
    Read More
  • View All RGA Articles

Related Solutions

Meet the Authors & Experts

Author
Dr. Daniel D. Zimmerman
Senior Vice President, Chief Science Advisor